Clinical Trial Update: Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing regional erector spinae analgesic block to standard of care in patients undergoing percutaneous nephrolithotomy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Stones

Drugs mentioned

• Regional erector spinae analgesic block

Snippet

Sponsor: Indiana University | Conditions: Kidney Stone, Surgery | Phase 4 | Status: TERMINATED